We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CTKB market cap is 541M. The company's latest EPS is USD -0.0943 and P/E is -44.54.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 48M | 58.23M | 44.86M | 46.62M | 51.5M |
| Operating Income | -6.42M | -1.64M | -10.73M | -8.53M | -4.25M |
| Net Income | -6.46M | 5.5M | -6.17M | -10.43M | 940k |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 92.84M | 127.95M | 164.04M | 193.02M |
| Operating Income | 13.66M | 9.16M | -1.8M | -27.85M |
| Net Income | 3.22M | 0 | 2.58M | -12.15M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 519.43M | 494.46M | 492.07M | 483.73M | 491.23M |
| Total Liabilities | 103.91M | 101.39M | 99.45M | 94.6M | 105.76M |
| Total Equity | 415.52M | 393.06M | 392.61M | 389.12M | 385.46M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 219.98M | 463.31M | 519.48M | 494.46M |
| Total Liabilities | 41.69M | 57.92M | 93.93M | 101.39M |
| Total Equity | -16.03M | 405.39M | 425.55M | 393.06M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -4.23M | 5.28M | 3.96M | 10.16M | 23.38M |
| Investing | -122.96M | -93.89M | -5.75M | -3.73M | -19.54M |
| Financing | -8.06M | -41.81M | 1.61M | -98k | -12.18M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 15.16M | 4.63M | -12.23M | 5.28M |
| Investing | -1.55M | -20.99M | -55.91M | -93.89M |
| Financing | 122.61M | 213.56M | 5.51M | -41.81M |
| Market Cap | 541M |
| Price to Earnings Ratio | -44.54 |
| Price to Sales Ratio | 2.8 |
| Price to Cash Ratio | 3.23 |
| Price to Book Ratio | 1.38 |
| Dividend Yield | - |
| Shares Outstanding | 128.81M |
| Average Volume (1 week) | 745.4k |
| Average Volume (1 Month) | 737.46k |
| 52 Week Change | -37.78% |
| 52 Week High | 7.63 |
| 52 Week Low | 4.05 |
| Spread (Intraday) | 0.3 (6.88%) |
| Company Name | Cytek Biosciences Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.cytekbio.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
